Journal
GASTROENTEROLOGY
Volume 161, Issue 4, Pages 1229-+Publisher
W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1053/j.gastro.2021.06.025
Keywords
Immunotherapy Colitis; Checkpoint Colitis; Ulcerative Colitis; Tofacitinib
Categories
Funding
- Oxford-Bristol Myers Squibb Postdoctoral Fellowship
- Norman Collisson Foundation Fellowship
- Oxford Health Services Research Committee grant
- Juvenile Diabetes Research Foundation [4-SRA-2017-473-A-A, 1-SRA-2019-657-A-N]
- Wellcome Trust [WT109965MA, 107212/A/15/Z]
- National Insitutes of Health [U192U19AI082630]
- National Institute for Health Research
- Oxford National Institute for Health Research Biomedical Research Centre
- Experimental Cancer Medicines Centres
Ask authors/readers for more resources
Our study demonstrates that CD8(+) tissue resident memory T (T-RM) cells are the main activated T cell subset in ICI colitis. The pattern of gastrointestinal immunopathology in ICI colitis is distinct from ulcerative colitis at both the immune and epithelial-signaling levels. Activation of CD8+ T-RM cells correlates with clinical and endoscopic severity of ICI colitis.
BACKGROUND & AIMS: The pathogenesis of immune checkpoint inhibitor (ICI)-colitis remains incompletely understood. We sought to identify key cellular drivers of ICI-colitis and their similarities to idiopathic ulcerative colitis, and to determine potential novel therapeutic targets. METHODS: We used a cross-sectional approach to study patients with ICI-colitis, those receiving ICI without the development of colitis, idiopathic ulcerative colitis, and healthy controls. A subset of patients with ICI-colitis were studied longitudinally. We applied a range of methods, including multiparameter and spectral flow cytometry, spectral immunofluorescence microscopy, targeted gene panels, and bulk and single-cell RNA sequencing. RESULTS: We demonstrate CD8(+) tissue resident memory T (T-RM) cells are the dominant activated T cell subset in ICI colitis. The pattern of gastrointestinal immunopathology is distinct from ulcerative colitis at both the immune and epithelial-signaling levels. CD8+ T-RM cell activation correlates with clinical and endoscopic ICI-colitis severity. Single-cell RNA sequencing analysis confirms activated CD8(+) T-RM cells express high levels of transcripts for checkpoint inhibitors and interferon-gamma in ICI-colitis. We demonstrate similar findings in both anti-CTLA-4/PD-1 combination therapy and in anti-PD-1 inhibitor-associated colitis. On the basis of our data, we successfully targeted this pathway in a patient with refractory ICI colitis, using the JAK inhibitor tofacitinib. CONCLUSIONS: Interferon gamma-producing CD8(+) T-RM cells are a pathological hallmark of ICI-colitis and a novel target for therapy.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available